We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Kerecis included on the list of covered products for Diabetic Foot Ulcers in the final LCD policy On 14 November 2024, the U.S. Centers for Medicare & Medicaid Services (CMS) issued a final...
Coloplast A/S - Notice of Annual General Meeting 2024 The Annual General Meeting of Coloplast A/S will be held onThursday, 5 December 2024 at 3:30 pm CETat the premises of Coloplast A/S, Holtedam...
Coloplast A/S - Annual Report 2023/24 & Remuneration Report 2023/24 Coloplast A/S - Annual Report 2023/24 & Remuneration Report 2023/24 FY 2023/24 organic growth of 8% and 27% EBIT...
Coloplast A/S - Full-Year Financial Results 2023/24 2023/24 Announcement of full-year financial results 1 October 2023 - 30 September 2024 Coloplast delivered Q4 organic growth of 8% and an EBIT...
Coloplast A/S - Announcement no. 05/2024 - Coloplast expands Executive Leadership Team Coloplast expands Executive Leadership Team Today, the Board of Directors have decided to expand the...
Coloplast A/S - FY 2023/24 Earnings Release - Invitation for conference call on 5 November 2024 at 11.00 CET Tuesday, 5 November 2024 at 11.00 – 12.00 CETIn connection with the publication of...
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons Please see enclosed pdf. Attachment 25092024_trading_in_shares_N_P_Louis-Hansen_ApS
Coloplast A/S - Financial Calendar 2024-25 Please see enclosed pdf. For more information and calendar invitations for upcoming events, please visit: https://investor.coloplast.com/investor-relation...
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons Please see enclosed pdf. Attachment 20092024_trading_in_shares_LRA
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons Please see enclosed pdf. Attachment 16092024_trading_in_shares_KV
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.7 | 0.599828620394 | 116.7 | 123 | 116.7 | 1185 | 120.18725953 | DE |
4 | -2.65 | -2.20741357768 | 120.05 | 125.45 | 113.6 | 1380 | 120.88399015 | DE |
12 | -4.15 | -3.414232826 | 121.55 | 128.5 | 113.6 | 1065 | 120.31178951 | DE |
26 | 3.3 | 2.89219982472 | 114.1 | 128.5 | 107.55 | 1240 | 117.5060993 | DE |
52 | 15.7 | 15.4375614553 | 101.7 | 131.15 | 100 | 1754 | 115.03535103 | DE |
156 | -40.45 | -25.6255939183 | 157.85 | 160.6 | 92.54 | 957 | 112.1522842 | DE |
260 | 9.4 | 8.7037037037 | 108 | 160.6 | 92.54 | 724 | 116.01854984 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions